Published in J Orthop Res on July 01, 2003
Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal (2011) 3.31
Craniofacial tissue engineering by stem cells. J Dent Res (2006) 2.48
TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci U S A (2011) 2.33
Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS One (2010) 2.01
Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J Lipid Res (2011) 1.94
Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther (2010) 1.59
Sonic Hedgehog influences the balance of osteogenesis and adipogenesis in mouse adipose-derived stromal cells. Tissue Eng Part A (2010) 1.32
Concise review: adipose-derived stromal cells for skeletal regenerative medicine. Stem Cells (2011) 1.16
Monolayer cell expansion conditions affect the chondrogenic potential of adipose-derived stem cells. Biotechnol Bioeng (2008) 1.14
Characterization of transplanted green fluorescent protein+ bone marrow cells into adipose tissue. Stem Cells (2007) 1.12
Nonintegrating knockdown and customized scaffold design enhances human adipose-derived stem cells in skeletal repair. Stem Cells (2011) 1.11
Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur. Mol Ther (2011) 1.10
Deleterious effects of freezing on osteogenic differentiation of human adipose-derived stromal cells in vitro and in vivo. Stem Cells Dev (2010) 1.08
Adipose tissue stem cells: the great WAT hope. Trends Endocrinol Metab (2012) 1.05
Pulsed direct current electric fields enhance osteogenesis in adipose-derived stromal cells. Tissue Eng Part A (2010) 1.02
Orthopedic gene therapy in 2008. Mol Ther (2008) 0.98
Adipose-derived stem cells in functional bone tissue engineering: lessons from bone mechanobiology. Tissue Eng Part B Rev (2011) 0.96
Bone regeneration by BMP-2 enhanced adipose stem cells loading on alginate gel. Histochem Cell Biol (2007) 0.95
Adipose-derived mesenchymal cells for bone regereneration: state of the art. Biomed Res Int (2013) 0.93
A clinically relevant model of osteoinduction: a process requiring calcium phosphate and BMP/Wnt signalling. J Cell Mol Med (2009) 0.91
Adipose tissue as a stem cell source for musculoskeletal regeneration. Front Biosci (Schol Ed) (2011) 0.90
Enhanced bone formation in large segmental radial defects by combining adipose-derived stem cells expressing bone morphogenetic protein 2 with nHA/RHLC/PLA scaffold. Int Orthop (2010) 0.89
Adipose-derived stem cells: a review of signaling networks governing cell fate and regenerative potential in the context of craniofacial and long bone skeletal repair. Int J Mol Sci (2014) 0.87
Tracking expression of virally mediated BMP-2 in gene therapy for bone repair. Clin Orthop Relat Res (2006) 0.86
Application of stem cells in bone repair. Skeletal Radiol (2008) 0.85
Designing biomaterials to direct stem cell fate. ACS Nano (2012) 0.85
The effect of surface demineralization of cortical bone allograft on the properties of recombinant adeno-associated virus coatings. Biomaterials (2008) 0.85
Advances in Adipose-Derived Stem Cells Isolation, Characterization, and Application in Regenerative Tissue Engineering. Stem Cells Int (2016) 0.84
Linear shear conditioning improves vascular graft retention of adipose-derived stem cells by upregulation of the alpha5beta1 integrin. Tissue Eng Part A (2010) 0.84
The potential of gene therapy for fracture healing in osteoporosis. Osteoporos Int (2005) 0.84
Gremlin in the pathogenesis of hepatocellular carcinoma complicating chronic hepatitis C: an immunohistochemical and PCR study of human liver biopsies. BMC Res Notes (2012) 0.82
Short (15 minutes) bone morphogenetic protein-2 treatment stimulates osteogenic differentiation of human adipose stem cells seeded on calcium phosphate scaffolds in vitro. Tissue Eng Part A (2012) 0.82
Repair of large segmental bone defects: BMP-2 gene activated muscle grafts vs. autologous bone grafting. BMC Biotechnol (2013) 0.80
The roles of bone morphogenetic proteins and their signaling in the osteogenesis of adipose-derived stem cells. Tissue Eng Part B Rev (2013) 0.80
Aesthetic cardiology: adipose-derived stem cells for myocardial repair. Curr Stem Cell Res Ther (2010) 0.80
Environmental parameters influence non-viral transfection of human mesenchymal stem cells for tissue engineering applications. Cell Tissue Res (2012) 0.80
Osteogenesis induced in goat bone marrow progenitor cells by recombinant adenovirus coexpressing bone morphogenetic protein 2 and basic fibroblast growth factor. Braz J Med Biol Res (2013) 0.79
Gene-enhanced tissue engineering for dental hard tissue regeneration: (1) overview and practical considerations. Head Face Med (2006) 0.79
Implants in bone: part I. A current overview about tissue response, surface modifications and future perspectives. Oral Maxillofac Surg (2013) 0.79
Stem cell therapy for bone repair: a systematic review and meta-analysis of preclinical studies with large animal models. Br J Clin Pharmacol (2014) 0.79
Addition of bone morphogenetic protein type 2 to ascorbate and β-glycerophosphate supplementation did not enhance osteogenic differentiation of human adipose-derived stem cells. J Appl Oral Sci (2013) 0.79
Pullulan/dextran/nHA macroporous composite beads for bone repair in a femoral condyle defect in rats. PLoS One (2014) 0.78
In silico Mechano-Chemical Model of Bone Healing for the Regeneration of Critical Defects: The Effect of BMP-2. PLoS One (2015) 0.78
Specific biomimetic hydroxyapatite nanotopographies enhance osteoblastic differentiation and bone graft osteointegration. Tissue Eng Part A (2013) 0.77
Physiology of bone turnover and its application in contemporary maxillofacial surgery. A review. Hippokratia (2010) 0.77
Fibrinogen Induces RUNX2 Activity and Osteogenic Development from Human Pluripotent Stem Cells. Stem Cells (2016) 0.77
Bone Morphogenetic Protein-2 Induces Donor-Dependent Osteogenic and Adipogenic Differentiation in Human Adipose Stem Cells. Stem Cells Transl Med (2015) 0.77
eNOS transfection of adipose-derived stem cells yields bioactive nitric oxide production and improved results in vascular tissue engineering. J Tissue Eng Regen Med (2013) 0.77
Regenerative strategies for craniofacial disorders. Front Physiol (2012) 0.77
Cyclic-RGD peptides increase the adenoviral transduction of human mesenchymal stem cells. Stem Cells Dev (2012) 0.76
Bone repair with skeletal stem cells: rationale, progress to date and clinical application. Ther Adv Musculoskelet Dis (2016) 0.76
Subcutaneous adipocytes may become osteoblasts. Clin Cases Miner Bone Metab (2012) 0.76
Lentivirus vector-mediated gene transduction of CNGRC peptide in rat adipose stem cells. Mol Med Rep (2014) 0.75
Adipose-Derived Stromal Vascular Fraction Differentially Expands Breast Progenitors in Tissue Adjacent to Tumors Compared to Healthy Breast Tissue. Plast Reconstr Surg (2015) 0.75
Characterization of the enhanced bone regenerative capacity of human periodontal ligament stem cells engineered to express the gene encoding bone morphogenetic protein 2. Tissue Eng Part A (2014) 0.75
Challenges of bone tissue engineering in orthopaedic patients. World J Orthop (2017) 0.75
Triptolide inhibits the function of TNF-α in osteoblast differentiation by inhibiting the NF-κB signaling pathway. Exp Ther Med (2017) 0.75
Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell (2002) 19.15
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med (2008) 6.32
Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med (2003) 3.96
Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs (2003) 3.70
Predictive models of molecular machines involved in Caenorhabditis elegans early embryogenesis. Nature (2005) 3.62
Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol (2006) 3.37
Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med (2005) 3.28
Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg (2004) 2.38
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty (2008) 2.30
Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone (2005) 2.26
Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am (2006) 2.15
Minimally invasive total hip arthroplasty. Development, early results, and a critical analysis. Presented at the Annual Meeting of the American Orthopaedic Association, Charleston, South Carolina, USA, June 14, 2003. J Bone Joint Surg Am (2003) 2.11
Supplementation of fat grafts with adipose-derived regenerative cells improves long-term graft retention. Ann Plast Surg (2010) 2.06
Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res (2005) 2.04
Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg (2014) 2.04
Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg (2002) 1.97
Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg (2006) 1.76
Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett (2003) 1.73
Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng (2005) 1.69
In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg (2003) 1.62
Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am (2005) 1.59
Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop Relat Res (2010) 1.57
A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PLoS One (2010) 1.52
Measurement scales in clinical research of the upper extremity, part 2: outcome measures in studies of the hand/wrist and shoulder/elbow. J Hand Surg Am (2013) 1.46
Characterization of osteolytic, osteoblastic, and mixed lesions in a prostate cancer mouse model using 18F-FDG and 18F-fluoride PET/CT. J Nucl Med (2008) 1.43
Measurement scales in clinical research of the upper extremity, part 1: general principles, measures of general health, pain, and patient satisfaction. J Hand Surg Am (2013) 1.43
Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res (2004) 1.42
Load-sharing at the wrist following radial head replacement with a metal implant. A cadaveric study. J Bone Joint Surg Am (2004) 1.41
The orthopaedic genome: what does the future hold and are we ready? J Bone Joint Surg Am (2002) 1.39
Developing a pathway for high-value, patient-centered total joint arthroplasty. Clin Orthop Relat Res (2013) 1.39
American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am (2009) 1.34
Osteoinductivity of commercially available demineralized bone matrix. Preparations in a spine fusion model. J Bone Joint Surg Am (2004) 1.27
Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. J Bone Miner Res (2005) 1.25
Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg (2009) 1.25
Primary total knee arthroplasty in California 1991 to 2001: does hospital volume affect outcomes? J Arthroplasty (2006) 1.24
Multilineage cells from adipose tissue as gene delivery vehicles. Hum Gene Ther (2003) 1.21
Cost-effectiveness analysis of unicompartmental knee arthroplasty as an alternative to total knee arthroplasty for unicompartmental osteoarthritis. J Bone Joint Surg Am (2006) 1.20
Perioperative complications of threaded cylindrical lumbar interbody fusion devices: anterior versus posterior approach. J Spinal Disord Tech (2003) 1.20
Human adipose stem cells: a potential cell source for cardiovascular tissue engineering. Cells Tissues Organs (2008) 1.20
Healing full-thickness cartilage defects using adipose-derived stem cells. Tissue Eng (2007) 1.19
Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg Am (2003) 1.19
Osteonecrosis of the hip: novel approaches to evaluation and treatment. Clin Orthop Relat Res (2007) 1.18
Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration. J Bone Miner Res (2006) 1.18
Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone. Bone (2008) 1.18
Whole-body skeletal imaging in mice utilizing microPET: optimization of reproducibility and applications in animal models of bone disease. Eur J Nucl Med Mol Imaging (2002) 1.17
Chondrogenic potential of multipotential cells from human adipose tissue. Plast Reconstr Surg (2004) 1.16
Processed lipoaspirate cells for tissue engineering of the lower urinary tract: implications for the treatment of stress urinary incontinence and bladder reconstruction. J Urol (2005) 1.16
Adipose tissue-derived cells improve cardiac function following myocardial infarction. J Surg Res (2008) 1.16
Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model. Cancer Res (2002) 1.16
Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes. Nat Clin Pract Cardiovasc Med (2006) 1.15
Mesenchymal stem cell concentration and bone repair: potential pitfalls from bench to bedside. J Bone Joint Surg Am (2009) 1.14
Tissue-engineered bone from BMP-2-transduced stem cells derived from human fat. Plast Reconstr Surg (2005) 1.14
The effect of age on osteogenic, adipogenic and proliferative potential of female adipose-derived stem cells. J Tissue Eng Regen Med (2009) 1.14
A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol Ther (2007) 1.13
A comparison of commercially available demineralized bone matrix for spinal fusion. Eur Spine J (2007) 1.10
Optimal timeframe for reporting short-term complication rates after total knee arthroplasty. J Arthroplasty (2006) 1.08
A Randomized, Controlled Trial of Total Knee Replacement. N Engl J Med (2016) 1.08
Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther (2005) 1.07
New genes with roles in the C. elegans embryo revealed using RNAi of ovary-enriched ORFeome clones. Genome Res (2005) 1.07
Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model. Spine (Phila Pa 1976) (2008) 1.06
Adult stem cell therapy for the heart. Int J Biochem Cell Biol (2004) 1.05
The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone. J Orthop Res (2005) 1.04
Bone graft for revision hip arthroplasty: biology and future applications. Clin Orthop Relat Res (2003) 1.04
Future of fat as raw material for tissue regeneration. Ann Plast Surg (2003) 1.04
Confocal microscopic analysis of scarless repair in the fetal rat: defining the transition. Plast Reconstr Surg (2002) 1.02
Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model. J Bone Joint Surg Am (2008) 1.02
Genetic modification of stem cells to enhance bone repair. Ann Biomed Eng (2004) 1.01
Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial. Ann Intern Med (2002) 1.00
Relaxin receptors in the human female anterior cruciate ligament. Am J Sports Med (2003) 1.00
Recurrent myxoma of the zygoma: a case report. J Oral Maxillofac Surg (2002) 1.00
An evaluation of human demineralized bone matrices in a rat femoral defect model. Clin Orthop Relat Res (2003) 1.00
Comparison of the responsiveness of the SF-36 and WOMAC in patients undergoing total hip arthroplasty. J Arthroplasty (2007) 0.98
Tumor metastasis to bone. Arthritis Res Ther (2007) 0.98
"Same day" ex-vivo regional gene therapy: a novel strategy to enhance bone repair. Mol Ther (2011) 0.97
The growing importance of fat in regenerative medicine. Trends Biotechnol (2005) 0.97
Reconstruction of the interosseous membrane of the forearm with a graft substitute: a cadaveric study. J Hand Surg Am (2005) 0.97
Gene therapy approaches to regenerating bone. Adv Drug Deliv Rev (2012) 0.97
Adipose-derived stem cells and BMP2: part 1. BMP2-treated adipose-derived stem cells do not improve repair of segmental femoral defects. Connect Tissue Res (2010) 0.96